NextCure, Inc.

NextCure, Inc.verified

NXTC

Price:

$2.075

Market Cap:

$5.56M

NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related conditions by reactivating normal immune system function. The company's leading investigational compound, NC318, is currently in Phase II clinical trials, focusing on the treatment of advanced or metastatic solid tumors. Additionally, NextCure is progressing NC410 through Phase I studies; this novel immunomedicine is engineered to counteract immune suppression mediated by Leukocyte-Associated Immunoglobulin-like Receptor 1 (LAIR-1). Another asset, NC762, is an immunotherapeutic designed to target the...[Read more]

Industry

Biotechnology

IPO Date

2019-05-09

Stock Exchange

NASDAQ

Ticker

NXTC

The Enterprise Value as of June 2026 (TTM) for NextCure, Inc. (NXTC) is -4681544.00

According to NextCure, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -4681544.00. This represents a change of -118.49% compared to the average of 25.31M of the last 4 quarters.

NextCure, Inc. (NXTC) Historical Enterprise Value (quarterly & annually)

How has NXTC Enterprise Value performed in the past?

The mean historical Enterprise Value of NextCure, Inc. over the last ten years is 233.94M. The current -4681544.00 Enterprise Value has changed -300.12% with respect to the historical average. Over the past ten years (40 quarters), NXTC's Enterprise Value was at its highest in in the December 2018 quarter at 2.26B. The Enterprise Value was at its lowest in in the March 2025 quarter at -2541793.60.

Quarterly (TTM)
Annual

Average

233.94M

Median

153.36M

Minimum

-221929.50

Maximum

855.17M

NextCure, Inc. (NXTC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NextCure, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 169.40%

Maximum Annual Enterprise Value = 855.17M

Minimum Annual Increase = -8888.98%

Minimum Annual Enterprise Value = -221929.50

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202519.51M-8888.98%
2024-221929.50-100.88%
202325.26M28.78%
202219.61M-87.21%
2021153.36M-43.37%
2020270.80M-68.33%
2019855.17M169.40%
2018317.44M-28.60%

NextCure, Inc. (NXTC) Average Enterprise Value

How has NXTC Enterprise Value performed in the past?

The current Enterprise Value of NextCure, Inc. (NXTC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.85M

5-year avg

43.50M

10-year avg

233.94M

NextCure, Inc. (NXTC) Enterprise Value vs. Peers

How is NXTC’s Enterprise Value compared to its peers?

NextCure, Inc.’s Enterprise Value is less than Q32 Bio Inc. (121.73M), less than Plus Therapeutics, Inc. (9.83M), less than Boundless Bio, Inc. (62.48M), less than Verrica Pharmaceuticals Inc. (41.88M), less than AN2 Therapeutics, Inc. (76.40M), greater than Jasper Therapeutics, Inc. (-5949824.00), less than Intensity Therapeutics, Inc. (-3315836.00), less than Pluri Inc. (50.39M), less than TAO Synergies Inc. (8.25M), less than Iterum Therapeutics plc (24.60M),

Build a custom stock screener for NextCure, Inc. (NXTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NextCure, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NextCure, Inc. (NXTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NextCure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NextCure, Inc.'s Enterprise Value?

What is the highest Enterprise Value for NextCure, Inc. (NXTC)?

What is the 3-year average Enterprise Value for NextCure, Inc. (NXTC)?

What is the 5-year average Enterprise Value for NextCure, Inc. (NXTC)?

How does the current Enterprise Value for NextCure, Inc. (NXTC) compare to its historical average?